Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,771 | 630 | 98.6% |
| Education | $154.88 | 18 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,487 | 68 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $1,066 | 77 | $0 (2022) |
| PFIZER INC. | $1,060 | 75 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $962.69 | 51 | $0 (2022) |
| Lilly USA, LLC | $668.09 | 44 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $564.15 | 33 | $0 (2022) |
| Merck Sharp & Dohme LLC | $536.04 | 37 | $0 (2022) |
| ABBVIE INC. | $501.03 | 21 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $480.41 | 24 | $0 (2022) |
| Novo Nordisk Inc | $424.12 | 23 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,305 | 72 | Amgen Inc. ($182.57) |
| 2021 | $2,125 | 118 | AbbVie Inc. ($239.63) |
| 2020 | $1,652 | 82 | Janssen Pharmaceuticals, Inc ($445.90) |
| 2019 | $1,888 | 114 | PFIZER INC. ($250.97) |
| 2018 | $2,143 | 147 | Amgen Inc. ($372.44) |
| 2017 | $1,812 | 115 | AstraZeneca Pharmaceuticals LP ($204.44) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Diabetes | ||||||
| 12/09/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Cardiovascular | ||||||
| 12/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 11/15/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Bone Health | ||||||
| 11/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: Cardiovascular | ||||||
| 10/28/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: ETONOGESTREL | ||||||
| 10/15/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Neuroscience | ||||||
| 10/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 10/08/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Cardio-renal | ||||||
| 10/07/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Inflammation | ||||||
| 09/30/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 09/30/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 09/30/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 09/30/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 09/23/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/20/2022 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: OB/GYN | ||||||
| 09/16/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 09/16/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 09/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: PRIMARY CARE | ||||||
| 09/09/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Inflammation | ||||||
| 09/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/26/2022 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, PAXLOVID | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 178 | 277 | $47,274 | $15,002 |
| 2021 | 7 | 223 | 305 | $48,983 | $12,713 |
| 2020 | 8 | 257 | 358 | $50,104 | $10,285 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 96 | $16,704 | $5,344 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 73 | $18,834 | $5,275 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $10,395 | $4,152 | 39.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 57 | $1,197 | $169.17 | 14.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 18 | $144.00 | $61.69 | 42.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 40 | 40 | $12,564 | $5,130 | 40.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 78 | $20,054 | $3,990 | 19.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 84 | $14,568 | $2,840 | 19.5% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 16 | 16 | $280.48 | $280.48 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $252.00 | $252.00 | 100.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 45 | 56 | $1,155 | $168.00 | 14.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 15 | $109.20 | $52.20 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 40 | 40 | $12,880 | $4,522 | 35.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 47 | 76 | $19,540 | $2,833 | 14.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 85 | $14,742 | $1,916 | 13.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 15 | 15 | $297.75 | $266.85 | 89.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 16 | $252.00 | $252.00 | 100.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 60 | 84 | $1,732 | $250.26 | 14.4% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 14 | 16 | $471.84 | $154.79 | 32.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 13 | 26 | $189.28 | $90.06 | 47.6% |
About Dr. Robert Larson, M.D
Dr. Robert Larson, M.D is a Family Medicine healthcare provider based in Kent, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881617488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Larson, M.D has received a total of $10,926 in payments from pharmaceutical and medical device companies, with $1,305 received in 2022. These payments were reported across 648 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($10,771).
As a Medicare-enrolled provider, Larson has provided services to 658 Medicare beneficiaries, totaling 940 services with total Medicare billing of $37,999. Data is available for 3 years (2020–2022), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Kent, WA
- Active Since 07/25/2006
- Last Updated 10/11/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881617488
Products in Payments
- XARELTO (Drug) $557.55
- FARXIGA (Drug) $535.26
- EVENITY (Biological) $517.14
- INVOKANA (Drug) $469.26
- ENTRESTO (Drug) $438.18
- ELIQUIS (Drug) $417.68
- TRULICITY (Drug) $407.05
- CHANTIX (Drug) $395.01
- Aimovig (Biological) $377.31
- JANUVIA (Drug) $313.82
- JARDIANCE (Drug) $298.43
- Trintellix (Drug) $273.74
- Prolia (Biological) $272.68
- NURTEC ODT (Drug) $267.50
- UBRELVY (Drug) $251.86
- Ozempic (Drug) $211.75
- Repatha (Biological) $192.90
- SYMBICORT (Drug) $173.16
- VIAGRA (Drug) $158.88
- EMGALITY (Drug) $149.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kent
Dr. Virginia Factor, D.o, D.O
Family Medicine — Payments: $9,097
Raymond Leone, D.o, D.O
Family Medicine — Payments: $4,892
Joshua Kretchmar, Do, DO
Family Medicine — Payments: $3,705
Miss. Charanjit Lamba, Md, MD
Family Medicine — Payments: $2,108
Dr. Lisa Kennedy, M.d, M.D
Family Medicine — Payments: $1,363
Joseph Chase, Md, MD
Family Medicine — Payments: $1,302